Trials / Completed
CompletedNCT06372223
A Food Effect Study of SPH5030 Tablets.
A Single-center, Randomized, Open, Single-dose, Two-cycle, Two-sequence Crossover Food Effect Study of SPH5030 Tablets in Healthy Chinese Adult Subjects.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Shanghai Pharmaceuticals Holding Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the food effect of SPH5030 tablets in healthy Chinese adult subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SPH5030 | SPH5030 tablets：400mg,orally, Dosing in the fasted state followed by fed dosing. |
| DRUG | SPH5030 | SPH5030 tablets：400mg, orally, Dosing in the fed state followed by fasted dosing. |
Timeline
- Start date
- 2024-03-04
- Primary completion
- 2024-03-25
- Completion
- 2024-03-25
- First posted
- 2024-04-17
- Last updated
- 2024-04-17
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06372223. Inclusion in this directory is not an endorsement.